Treatment monitoring and response prediction with proton MR spectroscopy in AD.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16894124.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this proton magnetic resonance spectroscopy ((1)H-MRS) study, the authors correlated cognitive improvement after 3 months of treatment with donepezil with changes of N-acetylaspartate (NAA) level and NAA/Creatine (Cr) ratio in the medial temporal and parietal lobe of 17 patients with Alzheimer disease. Treatment response was associated with an increase of NAA and NAA/Cr in the parietal lobe. Low baseline NAA/Cr in the parietal lobe predicted positive treatment outcome.
Medical subject headings
- Alzheimer Disease
- Aspartic Acid
- Creatine
- Magnetic Resonance Spectroscopy